KRYS

KRYSTAL BIOTECH INC

Healthcare | Mid Cap

$1.50

EPS Forecast

$114.3

Revenue Forecast

The company already released most recent quarter's earnings. We will publish our AI's next quarter's forecast around 2026-07-01

Proximilar's AI forecasts

EPS Forecast:

$1.50

Revenue Forecast:

$114.3

EPS Surprise Forecast:

$0.083

Revenue Surprise Forecast:

$2

Post-release price volatility - High

Post-release Overnight Move:

±7.5%

Post-release 1-week Move:

±

Odds of beating consensus

Probability of beating EPS consensus:

63%

Probability of beating revenue consensus:

56%

Probability of beating both EPS & revs consensus:

43%

Probability of missing both EPS & revs consensus:

23%

Surprise rating (from -5 to 5)

How unusually large is the +/- surprise we forecast:

-2

Beta (β)

Forward Looking Beta (β):

1.09

Earnings volatility

EPS standard deviation:

$0.72

Revenue standard deviation:

$35

As % of share price:

0.28% MEDIUM

As % of market cap:

0.47% MEDIUM

Confidence intervals and percentiles

EPS 95th %ile:

$2.48

Revenue 95th %ile:

$162

EPS 75th %ile:

$1.76

Revenue 75th %ile:

$127

EPS 25th %ile:

$1.30

Revenue 25th %ile:

$103

EPS 5th %ile:

$0.74

Revenue 5th %ile:

$75

Correlation of surprises (strength of relationship)

Correlation between EPS & revenue surprises:

45% HIGH

Earnings sensitivity to revenue surprises (slope of regression line)

Expected % of revenue surprise going to EPS:

27% HIGH

Stock's bid-ask spread

Bid-ask per $10K:

$31

Bid-ask per Share:

$0.8